Frontiers in Cardiovascular Medicine · Nov 17, 2026
The Effects of Different Exercise Modalities on Cardiac Function and Exercise Capacity in Patients with Stable Coronary Artery Disease: A Study Protocol for a Randomized Controlled Trial
By Shijie Hao, Xihua Liu, Xinzhuo Xu et al.
This single-blind, randomized controlled clinical trial investigates the efficacy and mechanisms by which different exercise types improve cardiac function and exercise capacity in patients with stable coronary artery disease. Seventy participants are randomly divided into three groups: control, aerobic exercise, and combined exercise. Eligible participants receive their respective interventions five times a week for six weeks. The control group receives standard care, including conventional medication, rehabilitation care, and health education. The aerobic exercise group receives aerobic exercise training in addition to standard care, and the combined exercise group receives aerobic and resistance training in addition to standard care. The primary outcome measures are exercise capacity parameters (VO2peak, VO2AT, O2pulse, Wpeak), left ventricular ejection fraction (LVEF), and serum BDNF level. Secondary outcome measures included heart rate variability parameters (HF, LF, LF/HF, SDNN, SDANN, and RMSSD), lipid metabolism indicators (TC, TG, LDL, and HDL), and inflammatory markers (CRP, IL-6, and TNF-α). The exploratory outcome measure is serum BDNF level. Safety assessments are conducted throughout the trial. Any adverse events that occur will be promptly addressed, documented, and reported. The researchers analyze the data without knowing the group assignments. Discussion: This study will provide strong evidence that different exercise modalities can improve cardiac function and exercise capacity and reduce the risk of adverse events in patients with stable coronary artery disease. By observing changes in serum BDNF levels before and after the intervention, we aim to explore potential associations between BDNF alterations and exercise-related cardiac adaptations. These findings may provide correlative clues for the hypothetical brain–heart axis framework, in which BDNF may be proposed as a candidate signaling molecule.